Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy

NeuroImage

Volumn 61, Issue 4, 2012, Pages 1165-1175

  Montoliu, Carmina ^b   Gonzalez Escamilla, Gabriel ^a   Atienza, Mercedes ^a   Urios, Amparo ^b   Gonzalez, Olga ^d   Wassel, Abdallah ^e   Aliaga, Roberto ^f   Giner Duran, Remedios ^d   Serra, Miguel A ^e   Rodrigo, Jose M ^g   Belloch, Vicente ^f   Felipo, Vicente ^c   Cantero, Jose L ^a  

^a UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^d HOSPITAL ARNAU DE VILANOVA   (Spain)

^e Hospital Clinico de Valencia   (Spain)

^f Hospital General Universitario Avda   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Cognitive impairment; Cortical thickness; Early diagnosis; Hepatic cirrhosis; Minimal hepatic encephalopathy

Indexed keywords

AMMONIA;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN DAMAGE; BRAIN REGION; BRAIN SIZE; BRAIN TISSUE; CALCARINE SULCUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL FLICKER FUSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GRAY MATTER; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER DISEASE; MALE; MINIMAL HEPATIC ENCEPHALOPATHY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRECUNEUS; PRIORITY JOURNAL; SCORING SYSTEM; TEMPORAL CORTEX; THICKNESS; TISSUE STRUCTURE;

CEREBRAL CORTEX; COGNITION DISORDERS; EARLY DIAGNOSIS; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84861335405     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.03.041     Document Type: Article

References (119)

1. Amodio P., Marchetti P., Del Piccolo F., de Tourtchaninoff M., Varghese P., Zuliani C., Campo G., Gatta A., Guerit J.M. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin. Neurophysiol. 1999, 110:1334-1344.
2. Amodio P., Del Piccolo F., Petteno E., Mapelli D., Angeli P., Iemmolo R., Muraca M., Musto C., Gerunda G., Rizzo C., Merkel C., Gatta A. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J. Hepatol. 2001, 35:37-45.
3. Amodio P., Pellegrini A., Amistà P., Luise S., Del Piccolo F., Mapelli D., Montagnese S., Musto C., Valenti P., Gatta A. Neuropsychological-neurophysiological alterations and brain atrophy in cirrhotic patients. Metab. Brain Dis. 2003, 18:63-78.
4. Amodio P., Valenti P., Del Piccolo F., Pellegrini A., Schiff S., Angeli P., Poci C., Mapelli D., Iannizzi P., Gatta A. P300 latency for the diagnosis of minimal hepatic encephalopathy: evidence that spectral EEG analysis and psychometric tests are enough. Dig. Liver Dis. 2005, 37:861-868.
5. Atienza M., Cantero J.L. Complex sound processing during human REM sleep by recovering information from long-term memory as revealed by the mismatch negativity (MMN). Brain Res. 2001, 901:151-160.
6. Atienza M., Cantero J.L., Gomez C.M. The mismatch negativity component reveals the sensory memory during REM sleep in humans. Neurosci. Lett. 1997, 237:21-24.
7. Bajaj J.S. Minimal hepatic encephalopathy matters in daily life. World J. Gastroenterol. 2008, 14:3609-3615.
8. Bajaj J.S., Cordoba J., Mullen K.D., Amodio P., Shawcross D.L., Butterworth R.F., Morgan M.Y. The design of clinical trials in hepatic encephalopathy-an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment. Pharmacol. Ther. 2011, 33:739-747.
9. Baldeweg T., Klugman A., Gruzelier J., Hirsch S.R. Mismatch negativity potentials and cognitive impairment in schizophrenia. Schizophr. Res. 2004, 69:203-217.
10. Barthauer L., Tarter R., Hirsch W., Van Thiel D. Brain morphologic characteristics of cirrhotic alcoholics and cirrhotic nonalcoholics: an MRI study. Alcohol Clin. Exp. Res. 1992, 16:982-985.
11. Bernal-Rusiel J.L., Atienza M., Cantero J.L. Detection of focal changes in human cortical thickness: spherical wavelets versus Gaussian smoothing. Neuroimage 2008, 41:1278-1292.
12. Bernal-Rusiel J.L., Atienza M., Cantero J.L. Determining the optimal level of smoothing in cortical thickness analysis: a hierarchical approach based on sequential statistical thresholding. Neuroimage 2010, 52:158-171.
13. Bosoi C.R., Rose C.F. Identifying the direct effects of ammonia on the brain. Metab. Brain Dis. 2009, 24:95-102.
14. Burra P., Dam M., Chierichetti F., Tedeschi U., Senzolo M., Sale E., Cagnin A., Ori C., Naccarato R., Ferlin G., Pizzolato G. 18F-fluorodeoxyglucose positron emission tomography study of brain metabolism in cirrhosis: effect of liver transplantation. Transplant. Proc. 1999, 31:418-420.
15. Butman J.A., Floeter M.K. Decreased thickness of primary motor cortex in primary lateral sclerosis. AJNR Am. J. Neuroradiol. 2007, 28:87-91.
16. Butterworth R.F. Neuronal cell death in hepatic encephalopathy. Metab. Brain Dis. 2007, 22:309-320.
17. Butterworth R.F. Altered glial-neuronal crosstalk: cornerstone in the pathogenesis of hepatic encephalopathy. Neurochem. Int. 2010, 57:383-388.
18. Butterworth R.F., Giguere J.F., Michaud J., Lavoie J., Layrargues G.P. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem. Pathol. 1987, 6:1-12.
19. Cagnin A., Taylor-Robinson S.D., Forton D.M., Banati R.B. In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy. Gut 2006, 55:547-553.
20. Cavada C., Goldman-Rakic P.S. Posterior parietal cortex in rhesus monkey: II. Evidence for segregated corticocortical networks linking sensory and limbic areas with the frontal lobe. J. Comp. Neurol. 1989, 287:422-445.
21. Cavanna A.E., Trimble M.R. The precuneus: a review of its functional anatomy and behavioural correlates. Brain 2006, 129:564-583.
22. Charil A., Dagher A., Lerch J.P., Zijdenbos A.P., Worsley K.J., Evans A.C. Focal cortical atrophy in multiple sclerosis: relation to lesion load and disability. Neuroimage 2007, 34:509-517.
23. Chen, H.J., Zhu, X.Q., Shu, H., Yang, M., Zhang, Y., Ding, J., Wang, Y., Teng G.J., in press. Structural and functional cerebral impairments in cirrhotic patients with a history of overt hepatic encephalopathy. Eur. J. Radiol.
24. Ciancio A., Marchet A., Saracco G., Carucci P., Lavezzo B., Leotta D., Capellero B., Nobili M., Smedile A., Rizzetto M. Spectral electroencephalogram analysis in hepatic encephalopathy and liver transplantation. Liver Transpl. 2002, 8:630-635.
25. Ciecko-Michalska I., Senderecka M., Szewczyk J., Panasiuk A., Slowik A., Wyczesany M., Binder M., Mach T. Event-related cerebral potentials for the diagnosis of subclinical hepatic encephalopathy in patients with liver cirrhosis. Adv. Med. Sci. 2006, 51:273-277.
26. Corbetta M., Shulman G.L., Miezin F.M., Petersen S.E. Superior parietal cortex activation during spatial attention shifts and visual feature conjunction. Science 1995, 270:802-805.
27. Dale A.M., Fischl B., Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999, 9:179-194.
28. Destrieux C., Fischl B., Dale A., Halgren E. Automatic parcellation of human cortical gyri and sulci using standard anatomical nomenclature. Neuroimage 2010, 53:1-15.
29. Ding S.L., Van Hoesen G.W., Cassell M.D., Poremba A. Parcellation of human temporal polar cortex: a combined analysis of multiple cytoarchitectonic, chemoarchitectonic, and pathological markers. J. Comp. Neurol. 2009, 514:595-623.
30. Duncan J.S., Papademetris X., Yang J., Jackowski M., Zeng X., Staib L.H. Geometric strategies for neuroanatomic analysis from MRI. Neuroimage 2004, 23(Suppl. 1):S34-S45.
31. Eckstein A.K., Reichenbach A., Jacobi P., Weber P., Gregor M., Zrenner E. Hepatic retinopathia. Changes in retinal function. Vision Res. 1997, 37:1699-1706.
32. Felipo V., Ordoño J.F., Urios A., Mlili N.E., Giménez-Garzó C., Aguado C., González-Lopez O., Giner-Durán R., Serra M.A., Wassel A., Rodrigo J.M., Salazar J., Montoliu C. Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests. Hepatology. 2012, 55:530-539.
33. Ferenci P., Lockwood A., Mullen K., Tarter R., Weissenborn K., Blei A.T. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35:716-721.
34. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11050-11055.
35. Fischl B., Sereno M.I., Dale A.M. Cortical surface-based analysis. II. Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999, 9:195-207.
36. Fischl B., Sereno M.I., Tootell R.B.H., Dale A.M. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum. Brain Mapp. 1999, 8:272-284.
37. Fischl B., Liu A., Dale A.M. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans. Med. Imaging 2001, 20:70-80.
38. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
39. Garcia-Martinez R., Rovira A., Alonso J., Aymerich F.X., Huerga E., Jacas C., Simon-Talero M., Vargas V., Cordoba J. A long-term study of changes in the volume of brain ventricles and white matter lesions after successful liver transplantation. Transplantation 2010, 89:589-594.
40. Good J., Ashburner C.D., Frackowiak R.S. Computational neuroanatomy: new perspectives for neuroradiology. Rev. Neurol. (Paris) 2001, 157:797-806.
41. Guevara M., Baccaro M.E., Gomez-Anson B., Frisoni G., Testa C., Torre A., Molinuevo J.L., Rami L., Pereira G., Sotil E.U., Cordoba J., Arroyo V., Gines P. Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy. J. Hepatol. 2011, 55:564-573.
42. Harper C.G., Butterworth R.F. Nutritional and metabolic disorders. Greenfield's Neuropathology 2002, 607-652. Arnold, London. D.I. Graham, P.L. Lantos (Eds.).
43. Häussinger D., Görg B. Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity. Curr. Opin. Clin. Nutr. Metab. Care 2010, 13:87-92.
44. Häussinger D., Laubenberger J., vom Dahl S., Ernst T., Bayer S., Langer M., Gerok W., Hennig J. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994, 107:1475-1480.
45. Heidelbaugh J.J., Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am. Fam. Physician 2006, 74:7560-7562.
46. Hollerbach S., Kullmann F., Fründ R., Lock G., Geissler A., Schölmerich J., Holstege A. Auditory event-related cerebral potentials (P300) in hepatic encephalopathy. Topographic distribution and correlation with clinical and psychometric assessment. Hepatogastroenterology 1997, 44:1002-1012.
47. Hughes S.W., Crunelli V. Thalamic mechanisms of EEG alpha rhythms and their pathological implications. Neuroscientist 2005, 11:357-372.
48. Iaria G., Petrides M. Occipital sulci of the human brain: variability and probability maps. J. Comp. Neurol. 2007, 501:243-259.
49. Iwasa M., Kinosada Y., Nakatsuka A., Watanabe S., Adachi Y. Magnetization transfer contrast of various regions of the brain in liver cirrhosis. AJNR Am. J. Neuroradiol. 1999, 20:652-654.
50. Kato A., Suzuki K., Kaneta H., Obara H., Fujishima Y., Sato S. Regional differences in cerebral glucose metabolism in cirrhotic patients with subclinical hepatic encephalopathy using positron emission tomography. Hepatol. Res. 2000, 17:237-245.
51. Kircheis G., Wettstein M., Timmermann L., Schnitzler A., Häussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 2002, 35:357-366.
52. Kitajima M., Korogi Y., Hirai T., Hamatake S., Ikushima I., Sugahara T., Shigematsu Y., Takahashi M., Mukuno K. MR changes in the calcarine area resulting from retinal degeneration. AJNR Am. J. Neuroradiol. 1997, 18:1291-1295.
53. Köstler H. Proton magnetic resonance spectroscopy in portal-systemic encephalopathy. Metab. Brain Dis. 1998, 13:291-301.
54. Kreis R., Ross B.D., Farrow N.A., Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992, 182:19-27.
55. Krieger S., Jauss M., Jansen O., Theilmann L., Geissler M., Krieger D. Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 1996, 111:147-155.
56. Kullmann F., Hollerbach S., Holstege A., Schölmerich J. Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials. J. Hepatol. 1995, 22:101-110.
57. Kullmann F., Hollerbach S., Lock G., Holstege A., Dierks T., Schölmerich J. Brain electrical activity mapping of EEG for the diagnosis of (sub)clinical hepatic encephalopathy in chronic liver disease. Eur. J. Gastroenterol. Hepatol. 2001, 13:513-522.
58. Kuperberg G.R., Broome M.R., McGuire P.K., David A.S., Eddy M., Ozawa F., Goff D., West W.C., Williams S.C., Van der Kouwe A.J., Salat D.H., Dale A.M., Fischl B. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch. Gen. Psychiatry 2003, 60:878-888.
59. Kutas M., McCarthy G., Donchin E. Augmenting mental chronometry: the P300 as a measure of stimulus evaluation time. Science 1977, 197:792-795.
60. Lalli S., Hussain Z., Ayub A., Cracco R.Q., Bodis-Wollner I., Amassian V.E. Role of the calcarine cortex (V1) in perception of visual cues for saccades. Clin. Neurophysiol. 2006, 117:2030-2038.
61. 1H-MRS) findings for the brain in patients with liver cirrhosis reflect the hepatic functional reserve. Am. J. Gastroenterol. 1999, 94:2206-2213.
62. Lefton H.B., Rosa A., Cohen M. Diagnosis and epidemiology of cirrhosis. Med. Clin. North Am. 2009, 93:787-799.
63. Lyoo I.K., Sung Y.H., Dager S.R., Friedman S.D., Lee J.Y., Kim S.J., Kim N., Dunner D.L., Renshaw P.F. Regional cerebral cortical thinning in bipolar disorder. Bipolar Disord. 2006, 8:65-74.
64. Makris N., Biederman J., Valera E.M., Bush G., Kaiser J., Kennedy D.N., Caviness V.S., Faraone S.V., Seidman L.J. Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder. Cereb. Cortex 2007, 17:1364-1375.
65. Mattarozzi K., Stracciari A., Vignatelli L., D'Alessandro R., Morelli M.C., Guarino M. Minimal hepatic encephalopathy: longitudinal effects of liver transplantation. Arch. Neurol. 2004, 61:242-247.
66. Mattarozzi K., Campi C., Guarino M., Stracciari A. Distinguishing between clinical and minimal hepatic encephalopathy on the basis of specific cognitive impairment. Metab. Brain Dis. 2005, 20:243-249.
67. Mechtcheriakov S., Graziadei I.W., Mattedi M., Bodner T., Kugener A., Hinterhuber H.H., Marksteiner J., Vogel W. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl. 2004, 10:77-83.
68. Menon K.V., Kamath P.S. Managing the complications of cirrhosis. Mayo Clin. Proc. 2000, 75:501-509.
69. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR Am. J. Neuroradiol. 2006, 27:1019-1026.
70. Miese F., Wittsack H.J., Kircheis G., Holstein A., Mathys C., Mödder U., Cohnen M. Voxel-based analyses of magnetization transfer imaging of the brain in hepatic encephalopathy. World J. Gastroenterol. 2009, 15:5157-5164.
71. Monfort P., Cauli O., Montoliu C., Rodrigo R., Llansola M., Piedrafita B., El Mlili N., Boix J., Agustí A., Felipo V. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications. Neurochem. Int. 2009, 55:106-112.
72. Moore J.W., Dunk A.A., Crawford J.R., Deans H., Besson J.A., De Lacey G., Sinclair T.S., Mowat N.A., Brunt P.W. Neuropsychological deficits and morphological MRI brain scan abnormalities in apparently healthy non-encephalopathic patients with cirrhosis. A controlled study. J. Hepatol. 1989, 9:319-325.
73. Mukamal K.J., Longstreth W.T., Mittleman M.A., Crum R.M., Siscovick D.S. Alcohol consumption and subclinical findings on magnetic resonance imaging of the brain in older adults: the cardiovascular health study. Stroke 2001, 32:1939-1946.
74. Näätänen R. Mismatch negativity: clinical research and possible applications. Int. J. Psychophysiol. 2003, 48:179-188.
75. Näätänen R. Mismatch negativity (MMN) as an index of central auditory system plasticity. Int. J. Audiol. 2008, 47(Suppl. 2):S16-S20.
76. Näätänen R., Alho K. Generators of electrical and magnetic mismatch responses in humans. Brain Topogr. 1995, 7:315-320.
77. Naegele T., Grodd W., Viebahn R., Seeger U., Klose U., Seitz D., Kaiser S., Mader I., Mayer J., Lauchart W., Gregor M., Voigt K. MR imaging and H spectroscopy of brain metabolites in hepatic encephalopathy: Time courses of renormalization after liver transplantation. Radiology 2000, 216:683-691.
78. Norenberg M.D., Rao K.V., Jayakumar A.R. Mechanisms of ammonia-induced astrocyte swelling. Metab. Brain Dis. 2005, 20:303-318.
79. Polich J., Kok A. Cognitive and biological determinants of P300: an integrative review. Biol. Psychol. 1995, 41:103-146.
80. Randolph C., Hilsabeck R., Kato A., Kharbanda P., Li Y.Y., Mapelli D., Ravdin L.D., Romero-Gomez M., Stracciari A., Weissenborn K. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN). Liver Int. 2009, 29:629-635.
81. Reddy P.V., Rama Rao K.V., Norenberg M.D. Inhibitors of the mitochondrial permeability transition reduce ammonia-induced cell swelling in cultured astrocytes. J. Neurosci. Res. 2009, 87:2677-2685.
82. Reinvang I. Cognitive event-related potentials in neuropsychological assessment. Neuropsychol. Rev. 1999, 9:231-248.
83. Riordan S.M., Williams R. Treatment of hepatic encephalopathy. N. Engl. J. Med. 1997, 337:473-479.
84. Rockland K.S., Ojimam H. Multisensory convergence in calcarine visual areas in macaque monkey. Int. J. Psychophysiol. 2003, 50:19-26.
85. Rodrigo R., Cauli O., Gomez-Pinedo U., Agusti A., Hernandez-Rabaza V., Garcia-Verdugo J.M., Felipo V. Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy. Gastroenterology 2010, 139:675-684.
86. Romero-Gomez M., Cordoba J., Jover R., del Olmo J., Fernandez A., Flavia M., Compañy L., Poveda M.J., Felipo V. Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy. Med. Clin. (Barcelona) 2006, 127:246-249.
87. Romero-Gomez M., Cordoba J., Jover R., del Olmo J.A., Ramirez M., Rey R., de Madaria E., Montoliu C., Nuñez D., Flavia M., Compañy L., Rodrigo J.M., Felipo V. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007, 45:879-885.
88. Rosas H.D., Liu A.K., Hersch S., Glessner M., Ferrante R.J., Salat D.H., van der Kouwe A., Jenkins B.G., Dale A.M., Fischl B. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002, 58:695-701.
89. Rovira A., Grive E., Pedraza S., Rovira A., Alonso J. Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR Am. J. Neuroradiol. 2001, 22:1137-1142.
90. Rovira A., Cordoba J., Raguer N., Alonso J. Magnetic resonance imaging measurement of brain edema in patients with liver disease: resolution after transplantation. Curr. Opin. Neurol. 2002, 15:731-737.
91. Rovira A., Alonso J., Cordoba J. MR imaging findings in hepatic encephalopathy. AJNR Am. J. Neuroradiol. 2008, 29:1612-1621.
92. Salat D.H., Buckner R.L., Snyder A.Z., Greve D.N., Desikan R.S., Busa E., Morris J.C., Dale A.M., Fischl B. Thinning of the cerebral cortex in aging. Cereb. Cortex 2004, 14:721-730.
93. Saxena N., Bhatia M., Joshi Y.K., Garg P.K., Tandon R.K. Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study. J. Gastroenterol. Hepatol. 2001, 16:322-327.
94. Schall J.D. Weighing the evidence: how the brain makes a decision. Nat. Neurosci. 1999, 2:108-109.
95. Scheperjans F., Eickhoff S.B., Hömke L., Mohlberg H., Hermann K., Amunts K., Zilles K. Probabilistic maps, morphometry, and variability of cytoarchitectonic areas in the human superior parietal cortex. Cereb. Cortex 2008, 18:2141-2157.
96. Schmahmann J.D., Pandya D.N. Anatomical investigation of projections from thalamus to posterior parietal cortex in the rhesus monkey: a WGA-HRP and fluorescent tracer study. J. Comp. Neurol. 1990, 295:299-326.
97. Segonne F., Dale A.M., Busa E., Glessner M., Salat D., Hahn H.K., Fischl B. A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004, 22:1060-1075.
98. Selemon L.D., Goldman-Rakic P.S. Common cortical and subcortical targets of the dorsolateral prefrontal and posterior parietal cortices in the rhesus monkey: evidence for a distributed neural network subserving spatially guided behavior. J. Neurosci. 1988, 8:4049-4068.
99. Sharma P., Sharma B.C., Puri V., Sarin S.K. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J. Hepatol. 2007, 47:67-73.
100. Sharma P., Sharma B.C., Sarin S.K. Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis. Hepatobiliary Pancreat. Dis. Int. 2010, 9:27-32.
101. Singh V., Chertkow H., Lerch J.P., Evans A.C., Dorr A.E., Kabani N.J. Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease. Brain 2006, 129:2885-2893.
102. Spahr L., Butterworth R.F., Fontaine S., Bui L., Therrien G., Milette P.C., Lebrun L.H., Zayed J., Leblanc A., Pomier-Layrargues G. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996, 24:1116-1120.
103. Srivastava A., Yadav S.K., Yachha S.K., Thomas M.A., Saraswat V.A., Gupta R.K. Pro-inflammatory cytokines are raised in extrahepatic portal venous obstruction, with minimal hepatic encephalopathy. J. Gastroenterol. Hepatol. 2011, 26:979-986.
104. Steriade M. Grouping of brain rhythms in cortico-thalamic systems. Neuroscience 2006, 137:1087-1106.
105. Stewart C.A., Smith G.E. Minimal hepatic encephalopathy. Nat. Clin. Pract. Gastroenterol. Hepatol. 2007, 4:677-685.
106. Stewart C.A., Malinchoc M., Kim W.R., Kamath P.S. Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl. 2007, 13:1366-1371.
107. Stewart C.A., Enders F.T., Schneider N., Felmlee-Devine D., Kamath P.S., Smith G.E. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy. Liver Int. 2010, 30:841-849.
108. Taylor-Robinson S.D., Buckley C., Changani K.K., Hodgson H.J.F., Bell J.D. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver 1999, 19:389-398.
109. Thuluvath P.J., Edwin D., Yue N.C., deVilliers C., Hochman S., Klein A. Increased signals seen in globus pallidus in T1-weighted magnetic resonance imaging in cirrhotics are not suggestive of chronic hepatic encephalopathy. Hepatology 1995, 21:440-442.
110. Ungerleider L.G., Haxby J.V. 'What' and 'where' in the human brain. Curr. Opin. Neurobiol. 1994, 157-165.
111. Van Essen H., Drury S., Miller J., Miller M. Functional and structural mapping of human cerebral cortex: solutions are in the surfaces. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:788-795.
112. Voets N.L., Hough M.G., Douaud G., Matthews P.M., James A., Winmill L., Webster P., Smith S. Evidence for abnormalities of cortical development in adolescent-onset schizophrenia. Neuroimage 2008, 43:665-675.
113. Wandell B.A. Computational neuroimaging of human visual cortex. Annu. Rev. Neurosci. 1999, 22:145-173.
114. Wein C., Koch H., Popp B., Oehler G., Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004, 39:739-745.
115. Weissenborn K., Ennen J.C., Schomerus H., Ruckert N., Hecker H. Neuropsychological characterization of hepatic encephalopathy. J. Hepatol. 2001, 34:768-773.
116. Weissenborn K., Heidenreich S., Ennen J., Rückert N., Hecker H. Attention deficits in minimal hepatic encephalopathy. Metab. Brain Dis. 2001, 16:13-19.
117. Winkler A.M., Kochunov P., Blangero J., Almasy L., Zilles K., Fox P.T., Duggirala R., Glahn D.C. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage 2010, 53:1135-1146.
118. Zafiris O., Kircheis G., Rood H.A., Boers F., Häussinger D., Zilles K. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study. Neuroimage 2004, 22:541-552.
119. Zeneroli M.L., Cioni G., Crisi G., Vezzelli C., Ventura E. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study. Magn. Reson. Imaging 1991, 9:295-302.